A team of renowned Southern California surgeons developed a breakthrough, minimally invasive technology that’s 36X more effective at treating Chronic Rhinosinusitis—and its root cause, biofilms—than anything currently available, offering relief to over 30 million patients worldwide. They partnered with us to build the Vayim brand and create the investor-facing materials needed to drive early-stage funding. Starting with their mission, vision, and values, we developed a complete identity system, including logo design, investment decks, and cross-channel communications. The result: Vayim successfully raised the capital needed to continue clinical trials and move toward FDA approval.